Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Roblox Corp — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while Roblox Corp trades at $46.71 (market cap $33.96B). The key difference: Roblox Corp is far larger — about 8.4× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Roblox Corp for 94 Days on average.
| INDV | RBLX | |
|---|---|---|
Market Cap | $4.03B | $33.96B |
Volume | 2,781,171 | 22,627,910 |
Sector | Health | Technology |
52-Week High | $41.83 | $138.56 |
52-Week Low | $24.09 | $35.54 |
Typical Hold Time | 0 Days | 94 Days |
Enterprise Value | $4.32B | $32.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Roblox (RBLX) trades at $49.53, down 0.12% on the day, with the stock showing resilience after recent volatility. The company continues to demonstrate strong revenue growth, reaching $4.89 billion in 2025, though profitability remains elusive with a net income margin of -17.61%. Technical indicators show a bullish trend with the current price near key resistance at $50, while analyst sentiment is mixed with a $52 consensus target. Recent news highlights both optimism around AI integration and concerns about bookings growth sustainability.
Roblox presents a growth story with expanding revenue and improving cash flow, but faces significant profitability challenges. The stock's upside potential hinges on continued user growth and margin improvement, while risks include intense competition and execution challenges in monetization. With mixed analyst ratings and high valuation multiples, investors should weigh the company's long-term platform potential against persistent losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
